학술논문

Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial Tumors.
Document Type
Article
Source
Oncologist; Apr2022, Vol. 27 Issue 4, pe353-e356, 4p, 2 Charts
Subject
ADVERSE health care events
EPITHELIAL cell tumors
IMMUNE checkpoint inhibitors
INFECTIOUS arthritis
JOINT diseases
RISK assessment
CANCER patients
POLYMYALGIA rheumatica
RHEUMATISM
MYOSITIS
IMMUNOTHERAPY
DISEASE risk factors
Language
ISSN
10837159
Abstract
Copyright of Oncologist is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)